questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the equity of access to encorafenib with cetuximab treatments for bowel cancer between in England compared to (a) Scotland and (b) Wales.
answerText: Department officials have not had any discussions with the Medicines and Healthcare products Regulatory Agency or the National Institute for Health and Care Excellence (NICE) about expediting the licensing and evaluation of the BREAKWATER treatment.The BR...
heading: Bowel Cancer: Medical Treatments